|
The influence of the cost of prescribed and OTC medicines on patient decision-making
Schafheutle EI, Hassell K, Weiss MC, Noyce PR School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Oxford Road, Manchester M13 9PL, UK
Introduction and aim
For patients who pay prescription charges, the cost of these, and
these in relation to the cost of over-the-counter (OTC) medicines, are
likely to influence their health care seeking and medicine-taking
behaviour. However, there is little research which examines how this
alters when people are forced to consider cost. The aim of this study
was to explore how charges for pharmaceuticals incurred by patients
influence their decision to utilise primary care services.
Method
Six focus groups were performed with between two and eight
participants. These were condition-specific with patients taking
medication, on prescription or OTC, for dyspepsia, hayfever or mild
hypertension, and HRT. They were recruited through three pharmacies
in Greater Manchester and Cheshire and two GP surgeries in Cheshire.
The first focus group was conducted with dyspepsia sufferers who were
exempt from paying prescription charges, the subsequent five were all
with people who had paid for their medicines either through
prescription charges or direct OTC purchase.
Results
Cost was identified as an influencing factor when making medication-
related decisions by patients who had to pay for their medication, and
this was particularly the case for people who were on a low income.
Cost played a different role for patients who did not have to pay for
their prescriptions in that their exemption steered them to consult
their GP for a free prescription, even when OTC products were
available. People who had to pay for their prescriptions had
developed a number of strategies to reduce their expense for
medicines. They would buy medication cheaper OTC, if they could, and
GPs sometimes advised this. Patients on regular multiple
prescriptions bought pre-payment certificates, but awareness of these
was not high, yet that of the cost of outlay was. Patients also said
that they sometimes did not get their prescription dispensed or only
in part if there were different items on it. Another strategy that
was mentioned by a few patients was that they would make their
medication last longer by taking a smaller than the recommended dose.
Even though, in previous focus groups, GPs had stated that patients
would ask them to reduce medication expense by, for example,
prescribing a longer supply, patients said that they did not actually
talk to their GP about cost issues.
Discussion
Cost of medicines clearly was an issue for patients who had to pay for
their medication, particularly those who were just above the income
threshold for exemption. Whether patients used cost-reduction
strategies depended on the perceived severity and risk of the
condition versus the perceived benefit of the medication (either long-
term in the case of, for example, hypertension, or symptom relief for
acute conditions). This study raises concerns about equity, but also
suggests that income problems may directly impact on the manner in
which people take their medicines and comply with treatment.
This work was designed and funded within the BIOMED program (Framework
IV) of the European Union and forms part of a national contribution of
a multinational study undertaken by ENDEP.
Presented at the HSRPP Conference 2000, Aberdeen
|